tiprankstipranks
Trending News
More News >
DiagnosTear Technologies, Inc. (TSE:DTR)
:DTR
Canadian Market
Advertisement

DiagnosTear Technologies, Inc. (DTR) Stock News & Sentiment

Compare
0 Followers
DiagnosTear Technologies Announces $700,000 Private Placement to Enhance Financial Position
Premium
Company Announcements
DiagnosTear Technologies Announces $700,000 Private Placement to Enhance Financial Position
4M ago
DiagnosTear Technologies Inc. Reports Successful AGM Outcomes
Premium
Company Announcements
DiagnosTear Technologies Inc. Reports Successful AGM Outcomes
5M ago
DiagnosTear’s TeaRx™ to be Showcased at ARVO 2025 for Groundbreaking DES Study Results
Premium
Company Announcements
DiagnosTear’s TeaRx™ to be Showcased at ARVO 2025 for Groundbreaking DES Study Results
7M ago

DTR News on the Web

News Score - Last 7 Days

Neutral
TSE:DTR
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:DTR’s Media Buzz Sentiment?
Currently, no data Available
What is TSE:DTR’s weekly average amount of articles?
Currently, no data Available
What is TSE:DTR’s News Sentiment?
59% of articles about TSE:DTR were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    ACADACADIA Pharmaceuticals
    ADUSAddus Homecare
    ARQTArcutis Biotherapeutics
    COLLCollegium Pharmaceutical
    TFXTeleflex
    Showing the stocks with the most bullish news sentiment over the past week
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis